A Prospective, Open-label, Single-arm, Investigator-initiated Study (SELIC) to Evaluate the Efficacy and Safety of Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (IC).

​ Conditions: Liver Transplant; Complications; Ischemic Cholangiopathy

Interventions: Drug: Seladelpar

Sponsors: University of California, San Diego

Not yet recruiting Conditions: Liver Transplant; Complications; Ischemic Cholangiopathy
Interventions: Drug: Seladelpar
Sponsors: University of California, San Diego
Not yet recruiting